|
Age
|
61 (56–66)
|
64 (57–68)
|
0,046
|
|
Women
|
49 (35,5%)
|
18 (29,5%)
|
0,41
|
|
HT
|
77 (55,8%)
|
34 (55,7%)
|
0,99
|
|
DM
|
22 (15,9%)
|
15 (25%)
|
0,13
|
|
Hypercholesterolemia
|
70 (50,7%)
|
27 (44,3%)
|
0,4
|
|
BSA
|
1,82 ± 0,2
|
1,91 ± 0,16
|
0,002
|
|
BMI
|
28,84 ± 4,29
|
30,07 ± 4,27
|
0,086
|
|
Peripheral arterial disease
|
13 (9,4%)
|
11 (18%)
|
0,085
|
|
CPD
|
20 (14,5%)
|
11 (18%)
|
0,52
|
|
Previous stroke
|
4 (2,9%)
|
4 (6,6%)
|
0,22
|
|
Previous neurological dysfunction
|
4 (2,9%)
|
0 (0%)
|
0,18
|
|
Preoperative creatinine concentration
|
0,94 (0,8–1,09)
|
1 (0,86–1,17)
|
0,043
|
|
Previous AF
|
18 (13%)
|
7 (11,5%)
|
0,76
|
|
Previous AMI
|
1 (0,7%)
|
1 (1,6%)
|
0,55
|
|
LVD
|
16 (11,6%)
|
7 (11,5%)
|
0,98
|
|
SPHT
|
14 (10,1%)
|
9 (14,8%)
|
0,35
|
|
Peak transaortic pressure gradient
|
81 (70–91)
|
81 (71–93)
|
0,93
|
|
Associated aortic regurgitation
|
27 (19,6%)
|
16 (26,2%)
|
0,29
|
|
Emergency surgery
|
4 (2,9%)
|
1 (1,6%)
|
0,61
|
|
Logistic EuroSCORE
|
2,8 (2,1–4,6)
|
2,9 (2,1–5,1)
|
0,51
|
|
Previous pacemaker implantation
|
0 (0%)
|
2 (3,3%)
|
0,033
|
|
NYHA functional class III-IV
|
67 (48,6%)
|
30 (49,2%)
|
0,93
|
|
Etiology
| | | |
|
Degenerative disease
|
90 (65,2%)
|
41 (67,2%)
|
0,78
|
|
Congenital disease
|
37 (26,8%)
|
13 (21,3%)
|
0,41
|
|
Rheumatic disease
|
11 (8%)
|
7 (11,5%)
|
0,43
|
